Completed PHASE2 INTERVENTIONAL NCT00045994

The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling

Systolic and Pulse Pressure Hemodynamic Improvement By Restoring Elasticity: The SILVER Study

Sponsor: Synvista Therapeutics, Inc

Conditions Hypertension Hypertrophy, Left Ventricular

Interventions ALT-711

Updated 5 times since 2017 Last updated: Jul 28, 2009 Started: Aug 31, 2001 Primary completion: Jan 31, 2002 Completion: Jun 30, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Hypertension and Hypertrophy, Left Ventricular, this trial is completed. The trial is conducted by Synvista Therapeutics, Inc and has accumulated 5 data snapshots since 2001. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Aug 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Synvista Therapeutics, Inc

Data source: Synvista Therapeutics, Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.